Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

S. pneumoniae CPS Antibodies

Streptococcus pneumoniae is a pathogen that was first isolated in 1880. Years later, this bacteria was recognized as the main agent causing pneumonia and as being capable of producing meningitis, otitis media, and other infectious diseases. S. pneumoniae are encapsulated, aerotolerant anaerobic, gram-positive bacteria. The capsular polysaccharide (CPS) constitutes the outermost layer of the bacterial cell and is the main virulence factor.

The CPS of S. pneumoniae were isolated in 1916. Some years later, capsular antigens were established as the basis of the serotypes of pneumococcal bacteria. In Streptococcus pneumoniae, CPS is also the primary target for vaccines, there are 98 currently recognized polysaccharide serotypes and protection is strictly serotype-specific. Polysaccharide pneumococcal vaccines have evolved over the past 20 years, using both unconjugated polysaccharides and polysaccharides conjugated to toxins to elicit a protective immune response in groups at risk for pneumococcal infection.

The pneumococcal CPS capsule is a surface structure located external to the cell wall. It protects the pathogen from host defense mechanisms. The virulence and invasiveness of pneumococcal strains vary according to the serotypes and depend on the chemical composition and amount of CPS produced. Several capsules are highly polar and hydrophilic, thus interfering with the interactions between the bacteria and phagocytes. Chemical structure studies of this antigen reveal that most types contain a negatively charged capsule (except for serotypes 7 and 14, which are neutral) and acid components, such as glucuronic acid (in types 1, 2, 3, 5, 8, 9A, and 9V), or phosphate in phosphodiester bonds (in types 6A, 6B, 11A, 15F, 19F, 19A, and 23F).

Creative Diagnostics has developed a panel of serotype-specific S. pneumoniae CPS antibodies for streptococcus pneumoniae vaccines research. These antibodies are manufactured to the highest quality standards and are performance guaranteed for the applications listed on the detailed datasheets.

<
Cat. No. Product Name Application
CABT-CS118Mouse Anti-S. pneumoniae CPS 1 MAb, clone 1227 ELISAInquiry    
CABT-CS119Mouse Anti-S. pneumoniae CPS 3 MAb, clone 1216 ELISAInquiry    
CABT-CS120Mouse Anti-S. pneumoniae CPS 4 MAb, clone 1220 ELISAInquiry    
CABT-CS121Mouse Anti-S. pneumoniae CPS 5 MAb, clone 1221 ELISAInquiry    
CABT-CS122Mouse Anti-S. pneumoniae CPS 6A MAb, clone 1217 ELISAInquiry    
CABT-CS123Mouse Anti-S. pneumoniae CPS 6B MAb, clone 1231 ELISAInquiry    
CABT-CS124Mouse Anti-S. pneumoniae CPS 7F MAb, clone 1245 ELISAInquiry    
CABT-CS125Mouse Anti-S. pneumoniae CPS 8 MAb, clone 1233 ELISAInquiry    
CABT-CS126Mouse Anti-S. pneumoniae CPS 9N MAb, clone 1230 ELISAInquiry    
CABT-CS127Mouse Anti-S. pneumoniae CPS 9V MAb, clone 1225 ELISAInquiry    
CABT-CS128Mouse Anti-S. pneumoniae CPS 11A MAb, clone 1234 ELISAInquiry    
CABT-CS129Mouse Anti-S. pneumoniae CPS 14 MAb, clone 1229 ELISAInquiry    
CABT-CS130Mouse Anti-S. pneumoniae CPS 17F MAb, clone 1235 ELISAInquiry    
CABT-CS131Mouse Anti-S. pneumoniae CPS 18 MAb, clone 1224 ELISAInquiry    
CABT-CS132Mouse Anti-S. pneumoniae CPS 19A MAb, clone 1219 ELISAInquiry    
CABT-CS133Mouse Anti-S. pneumoniae CPS 19F MAb, clone 1215 ELISAInquiry    
CABT-CS134Mouse Anti-S. pneumoniae CPS 20 MAb, clone 1262 ELISAInquiry    
CABT-CS135Mouse Anti-S. pneumoniae CPS 23F MAb, clone 1263 ELISAInquiry    
CABT-CS136Mouse Anti-S. pneumoniae CPS 33F MAb, clone 1264 ELISAInquiry    
Inquiry Basket
loading Loading ......

Inquiry

Inquiry